5-13882966-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001369.3(DNAH5):​c.3112G>A​(p.Val1038Met) variant causes a missense change. The variant allele was found at a frequency of 0.00132 in 1,614,174 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00070 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 37 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

1
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 5.77
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0049948096).
BP6
Variant 5-13882966-C-T is Benign according to our data. Variant chr5-13882966-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 215493.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-13882966-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000696 (106/152296) while in subpopulation SAS AF= 0.0182 (88/4828). AF 95% confidence interval is 0.0152. There are 2 homozygotes in gnomad4. There are 79 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DNAH5NM_001369.3 linkuse as main transcriptc.3112G>A p.Val1038Met missense_variant 20/79 ENST00000265104.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DNAH5ENST00000265104.5 linkuse as main transcriptc.3112G>A p.Val1038Met missense_variant 20/791 NM_001369.3 P4
ENST00000503244.2 linkuse as main transcriptn.254-13623C>T intron_variant, non_coding_transcript_variant 4
DNAH5ENST00000681290.1 linkuse as main transcriptc.3067G>A p.Val1023Met missense_variant 20/79 A1
ENST00000637153.1 linkuse as main transcriptn.214-13623C>T intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000683
AC:
104
AN:
152178
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0178
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00273
AC:
687
AN:
251348
Hom.:
11
AF XY:
0.00351
AC XY:
477
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.000326
Gnomad SAS exome
AF:
0.0209
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00138
AC:
2017
AN:
1461878
Hom.:
37
Cov.:
34
AF XY:
0.00194
AC XY:
1408
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.000497
Gnomad4 EAS exome
AF:
0.000202
Gnomad4 SAS exome
AF:
0.0201
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.0000809
Gnomad4 OTH exome
AF:
0.00237
GnomAD4 genome
AF:
0.000696
AC:
106
AN:
152296
Hom.:
2
Cov.:
33
AF XY:
0.00106
AC XY:
79
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.000577
Gnomad4 EAS
AF:
0.000771
Gnomad4 SAS
AF:
0.0182
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000291
Hom.:
0
Bravo
AF:
0.000249
ExAC
AF:
0.00283
AC:
344
Asia WGS
AF:
0.0140
AC:
47
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 16, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Jan 10, 2020- -
Primary ciliary dyskinesia 3 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesApr 06, 2022- -
not provided Benign:1
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.082
T
Eigen
Benign
0.15
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0050
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Pathogenic
3.0
M
MutationTaster
Benign
1.0
D
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.17
Sift
Benign
0.073
T
Polyphen
0.80
P
Vest4
0.73
MVP
0.47
MPC
0.31
ClinPred
0.091
T
GERP RS
5.2
Varity_R
0.077
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146828513; hg19: chr5-13883075; API